InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Shukla Sanjay, Chief Executive Officer. Insider active across 2 companies, notably aTYR PHARMA INC. In total, 6 filings have been recorded. Total volume traded: €163k. The latest transaction was filed on 7 January 2022 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
€29,9265,000 shares@ €5.985161.5% of flow
Common Stock
SEC:0001209191-22-002768·
Ideal exit: 4 Oct 2022 (T+270)
€29,9265,000 shares@ €5.98510.039% mcap26.2% of flow
Common Stock
SEC:0001209191-22-002768:0·
Ideal exit: 4 Oct 2022 (T+270)
€18,7362,500 shares@ €7.494538.5% of flow
Common Stock
SEC:0001209191-21-064565·
Ideal exit: 12 Aug 2022 (T+270)
€18,7362,500 shares@ €7.49450.024% mcap16.4% of flow
Common Stock
SEC:0001209191-21-064565:0·
Ideal exit: 12 Aug 2022 (T+270)
€32,80410,000 shares@ €3.2804100.0% of flow
Common Stock
SEC:0001209191-21-034292·
Ideal exit: 12 Feb 2022 (T+270)
€32,80410,000 shares@ €3.28040.043% mcap28.7% of flow
Common Stock
SEC:0001209191-21-034292:0·
Ideal exit: 12 Feb 2022 (T+270)
6 of 6 declarations
About Shukla Sanjay
Sanjay Shukla is the President and CEO of aTYR PHARMA INC. He is responsible for the strategic direction of the company, focusing on innovation in the pharmaceutical sector. His leadership is essential for achieving growth and profitability objectives.
